Skip to main content

Fulcrum Asset Management LLP

Position in BSX — Boston Scientific Corp

CIK 1353395 LONDON, X0

Position in BSX

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$2,038,524
-$650,376 QoQ
Shares Held
47,763
+11.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#561
of 1,468 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$3,860,475
PutShares
38,268

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Fulcrum Asset Management LLP holds $10,730,982 across 21 Medical Devices names. BSX ranks #2 (19.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BSX
Boston Scientific Corp
This page
47,763 $2,038,524

All Filings in BSX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,038,524 47,763
2026-03-31 $2,688,900 42,851
2025-12-31 $3,676,600 38,559
2025-09-30 $3,876,008 39,701
2025-06-30 $4,382,757 40,804
2025-03-31 $3,860,475 38,268
2024-12-31 $3,589,413 40,186
2024-09-30 $2,513,581 29,995
2024-06-30 $2,372,832 30,812
2022-03-31 $459,420 10,373
2021-12-31 $629,638 14,822
2021-09-30 $643,126 14,822
2021-06-30 $610,000 0
2021-03-31 $534,722 13,835